January 20, 2024 18:24 (London Time)

Blueprint Medicines

Youtube Subscribe

Sector: Biotechnology

Ticker: BPMC

Sentiment: -0.25

MarketCap: 4,927,006,157.0

High: 81.68 Low: 78.79

Open: 80.05 Close: 81.05 Change: 1.0

You're losing the opportunity of using an AI to get informed about Blueprint Medicines.

Are looking for the most relevant information about Blueprint Medicines? Investor spend a lot of time searching for information to make investment decisions in Blueprint Medicines. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Blueprint Medicines are: Blueprint, Medicines, analyst, price, target, medicine, BPMC, and the most common words in the summary are: blueprint, medicine, stock, cancer, news, new, analyst, . One of the sentences in the summary was: Blueprint Medicines stock (nasdaq:bpmc), quotes and news summary - benzinga. Other …

Concept Map

Semantic Network

Stock Summary

Blueprint Medicines reported a loss of $2.19 per share for the second quarter of 2023, narrower than the Zacks Consensus Estimate of a loss. Shares were down about 10% during pre-market hours on Wednesday.

Today's Summary

Blueprint Medicines (BPMC) has 8.03% upside potential, based on the analysts average price target. The average one-year price target for the company has been revised to 89.28 / share. Blueprint Medicine is a global precision therapy company that invents life-changing medicines for people with cancer. JMP Securities analyst Reni Benjamin reiterates Blueprint Medicines (NASDAQ: BPMC) with a Market Outperform and maintains $114 price target. Peeling back the layers: exploring blueprint medicines through analyst insights. Blueprint Medicines stock (nasdaq:bpmc), quotes and news summary - benzinga. blueprint medicines stock (NASdaq: bpmc) quotes and. news summary.

Today's News

Stock Profile

" Blueprint Medicines Corp. has generated a BUY signal for shortterm two days back! The share prices have been rising up shortly. The USA share BPMC Blueprint Medicine appears to be moving upwards constantly. Blueprint Medicines (NASDAQ:BPMC) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Heres what investors need to know before the announcement. Blueprint Medicines reported a loss of $2.19 per share for the second quarter of 2023, narrower than the Zacks Consensus Estimate of a loss. Shares were down about 10% during pre-market hours on Wednesday. Blueprint Medicines Corp (BPMC) earnings, actual eps, eps estimates & results. blueprint medicines corp (bpmc) Earnings, actual EPS, EPS Estimates & Results Stocktwits Join the conversation! Build your trading network. Blueprint Medicines stock price per share is $64.14 today (as of Aug 1, 2023). What is Blueprint Mediciness Market Cap? (NASDAQ : BPMC) Blueprint Medicine s market cap is $3.88B. Blueprint Medicines Co. opened at $63.12 on Friday. Needham & Company LLC reaffirmed a “buy” rating and set a $57.00 price objective on shares of Blueprint Medicine in a research note on Wednesday, April 19th. Barclays raised their price objective at $44.00 to $46.00 on Tuesday, May 23rd. 19 investment analysts have recommended buying stock in Blueprint Medicines Corp. Overall, the consensus among analysts is to buy stock. Over the course of the last 52 weeks, Blueprint Medicine shares have experienced an increase of 8.99%."

Keywords

The game is changing. There is a new strategy to evaluate Blueprint Medicines fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Blueprint Medicines are: Blueprint, Medicines, analyst, price, target, medicine, BPMC, and the most common words in the summary are: blueprint, medicine, stock, cancer, news, new, analyst, . One of the sentences in the summary was: Blueprint Medicines stock (nasdaq:bpmc), quotes and news summary - benzinga. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #blueprint #medicine #stock #cancer #news #new #analyst.

January 20, 2024 18:24 (London Time)